Annual Working Capital
$212.63 M
+$16.64 M+8.49%
31 December 2023
Summary:
Kiniksa Pharmaceuticals annual working capital is currently $212.63 million, with the most recent change of +$16.64 million (+8.49%) on 31 December 2023. During the last 3 years, it has risen by +$61.01 million (+40.24%). KNSA annual working capital is now -29.45% below its all-time high of $301.40 million, reached on 31 December 2020.KNSA Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Working Capital
$215.35 M
-$1.38 M-0.64%
30 September 2024
Summary:
Kiniksa Pharmaceuticals quarterly working capital is currently $215.35 million, with the most recent change of -$1.38 million (-0.64%) on 30 September 2024. Over the past year, it has increased by +$2.71 million (+1.28%). KNSA quarterly working capital is now -39.09% below its all-time high of $353.52 million, reached on 30 September 2020.KNSA Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
KNSA Working Capital Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | +1.3% |
| 3 y3 years | +40.2% | +42.0% |
| 5 y5 years | -0.6% | +0.7% |
KNSA Working Capital High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +40.2% | -0.6% | +57.9% |
| 5 y | 5 years | -29.4% | +40.2% | -39.1% | +57.9% |
| alltime | all time | -29.4% | +616.6% | -39.1% | +625.7% |
Kiniksa Pharmaceuticals Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $215.35 M(-0.6%) |
| June 2024 | - | $216.73 M(+5.0%) |
| Mar 2024 | - | $206.38 M(-2.9%) |
| Dec 2023 | $212.63 M(+8.5%) | $212.63 M(+4.9%) |
| Sept 2023 | - | $202.64 M(+2.1%) |
| June 2023 | - | $198.57 M(+1.9%) |
| Mar 2023 | - | $194.91 M(-0.6%) |
| Dec 2022 | $195.99 M(+29.3%) | $195.99 M(+5.8%) |
| Sept 2022 | - | $185.32 M(+35.9%) |
| June 2022 | - | $136.39 M(-8.1%) |
| Mar 2022 | - | $148.40 M(-2.1%) |
| Dec 2021 | $151.62 M | $151.62 M(-17.2%) |
| Sept 2021 | - | $183.09 M(-11.1%) |
| June 2021 | - | $206.03 M(-14.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2021 | - | $240.11 M(-20.3%) |
| Dec 2020 | $301.40 M(+41.0%) | $301.40 M(-14.7%) |
| Sept 2020 | - | $353.52 M(+44.9%) |
| June 2020 | - | $243.94 M(+25.9%) |
| Mar 2020 | - | $193.71 M(-9.4%) |
| Dec 2019 | $213.80 M(-21.2%) | $213.80 M(-11.2%) |
| Sept 2019 | - | $240.78 M(-9.6%) |
| June 2019 | - | $266.28 M(-10.7%) |
| Mar 2019 | - | $298.06 M(+9.9%) |
| Dec 2018 | $271.20 M(+813.9%) | $271.20 M(-13.5%) |
| Sept 2018 | - | $313.51 M(-8.0%) |
| June 2018 | - | $340.73 M(+67.7%) |
| Mar 2018 | - | $203.19 M(+584.7%) |
| Dec 2017 | $29.67 M(-45.1%) | $29.67 M |
| Dec 2016 | $54.03 M | - |
FAQ
- What is Kiniksa Pharmaceuticals annual working capital?
- What is the all time high annual working capital for Kiniksa Pharmaceuticals?
- What is Kiniksa Pharmaceuticals quarterly working capital?
- What is the all time high quarterly working capital for Kiniksa Pharmaceuticals?
- What is Kiniksa Pharmaceuticals quarterly working capital year-on-year change?
What is Kiniksa Pharmaceuticals annual working capital?
The current annual working capital of KNSA is $212.63 M
What is the all time high annual working capital for Kiniksa Pharmaceuticals?
Kiniksa Pharmaceuticals all-time high annual working capital is $301.40 M
What is Kiniksa Pharmaceuticals quarterly working capital?
The current quarterly working capital of KNSA is $215.35 M
What is the all time high quarterly working capital for Kiniksa Pharmaceuticals?
Kiniksa Pharmaceuticals all-time high quarterly working capital is $353.52 M
What is Kiniksa Pharmaceuticals quarterly working capital year-on-year change?
Over the past year, KNSA quarterly working capital has changed by +$2.71 M (+1.28%)